BNRG has shed nearly a fifth of its value in a month — and the cost to borrow shares hasn't let up once.
The most telling feature of the current setup is the borrow market. Cost to borrow has climbed to around 32–34% annualised — up roughly 57% from a month ago — making this one of the more expensive small-cap names to short on Nasdaq right now. The rate has held above 30% for most of the past three weeks, dipping briefly to 21% on May 7 before snapping back. That kind of stickiness at elevated levels reflects persistent demand for borrows, even as the share count on loan has actually declined. Availability data is not current enough to give a precise read on the lending pool, but the cost trajectory alone signals a tight borrow environment.
Short interest tells a nuanced story here. On the raw FINRA numbers, shorts amount to about 7.4% of the free float — meaningful for a micro-cap name, and well above the near-zero levels seen briefly in mid-April. But the longer view is stark: short interest collapsed from above 80% of float in early April (when ORTEX estimates reflected a trading halt and its aftermath) down to the current level, a fall of over 91% in a month by share count. That is not a short squeeze in the traditional sense — it is a structural reset following whatever drove the April 9 halt and subsequent resumption. With the position now at a more modest 7.4% of float and borrow costs elevated, the remaining shorts are paying a premium to hold, but are not facing a crowded-exit problem.
The ORTEX short score of 51.7 places BNRG in a middle range — not at extremes, but trending up from readings in the mid-40s a week ago. The DTC rank in the 78th percentile reflects a stock with thin enough volume that even the current small short position takes about a day to cover. Factor scores are sparse: the sector score lands at the 50th percentile, and the dividend score of 24 is a non-factor for a pre-profit clean-energy hardware company. No analyst coverage is in the system with current data, so the Street view is effectively absent here.
A notable item in the ownership data: company founder Avraham Brenmiller last reported holding just 782 shares as of March 2026, down 2,941 shares from the prior filing. That is a small absolute position, but founder trimming at a time when the stock is down sharply is worth flagging. The insider transaction table only has trades from 2021–22, well beyond the 90-day window, so no useful recent signal there. On the institutional side, Alpha Capital Anstalt remains the largest reported holder with a 2.3% stake, unchanged as of September 2025.
Past earnings events have produced sharp moves in both directions. The March 25, 2026 announcement drew a 4.5% drop on the day and an 8% slide over the following week. The prior event in March 2026 went the other way — up 5% on day one, then 22% over five days. Before that, a December 2025 report triggered a 37% five-day loss. The stock's next scheduled event is May 22, just over a week away. Peers DFLI and XPON each fell 8–9% on the week, broadly in line with BNRG's 10% decline, suggesting the move is partly sector-driven rather than purely company-specific.
The May 22 earnings release is the next pivot point: given the history of large post-event swings and an already-stressed borrow market, the cost to hold a short position into that print is the arithmetic the remaining bears will be running between now and then.
See the live data behind this article on ORTEX.
Open BNRG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
